Cargando…
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy
Tissue factor pathway inhibitor (TFPI) is an alternatively spliced anticoagulant protein that primarily dampens the initiation phase of coagulation before thrombin is generated. As such, TFPI’s actions are localized to cells expressing TF and to sites of injury, where it is an important regulator of...
Autores principales: | Mast, Alan E., Ruf, Wolfram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314982/ https://www.ncbi.nlm.nih.gov/pubmed/35279938 http://dx.doi.org/10.1111/jth.15697 |
Ejemplares similares
-
Coagulation Factor IX for Hemophilia B Therapy
por: Orlova, N. A., et al.
Publicado: (2012) -
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2018) -
MG1113, a specific anti–tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia
por: Kwak, Heechun, et al.
Publicado: (2020) -
Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy
por: Heestermans, Marco, et al.
Publicado: (2017) -
Roles of factor Xa beyond coagulation
por: Ruf, Wolfram
Publicado: (2021)